TEL：
Main products: Intermediate of Umeclidinium bromide,Vilanterol Trifenate,Empagliflozin.
NEWS CENTER
-
top Reco Embrace the Phar...
We are excited to inform you that Hengsheng DeKang (Nanjing) Pharmaceutical Technology Co., Ltd. will be participating in the upcoming CPHI China Exhibition for Active Pharmaceutical Ingredients (API) at the Shanghai New International Expo Center from June 19th to 21st, 2023. We extend a warm invitation to you to visit us at booth N2G23 during this significant industry event.
MORE -
top Reco Recruitment posi...
Recruitment position: synthesis researcher (5-8 persons)
MORE -
top Reco Elagolix, the he...
Elagolix has been considered as a potential blockbuster drug. It is one of several top drugs of Abbott's later R & D pipeline. It is also one of Abbott's best business trumps after humoral. Evalua
MORE -
top Reco HSDK（Nanjing）Pha...
HSDK（Nanjing）Pharma Tech Co.，Ltd. was established in 2020. The company is located in the R&D Center of Nanjing Chemical Industry Park, a National Chemical Park. It is a high-tech company integrating R
MORE -
Non clinical dev...
Epilepsy is one of the highest incidence rate of neurological diseases. Over 50 million people worldwide have epilepsy. The incidence rate in developed countries is about 40-70/10 million per year. In
MORE -
Summary of recen...
国务院《关于加强推进生态文明建设的意见》《生态文明体制改革总体方案》《关于建立统一的绿色产品标准、认证、标识体系的意见》中提出我国将建立统一的绿色产品体系，要提供更多绿色产品，培育绿色消费，积极引导消费者购买绿色产品。
MORE -
Ash targeted the...
This study was based on a meta-analysis of 370 MCL patients and a 3.5-year follow-up. The patients were mainly treated with irutinib. As part of three open-end studies, the follow-up was cross conduct
MORE
CONTACT US
TELPHONE：025-52440010
WEBISTE：www.hsdk-pharmatech.cn
ADDRESS：Building H, No. 22 Tiansheng Road, Jiangbei New Area, Nanjing City, Jiangsu Province, China
客服7